These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 29085193

  • 21. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [Abstract] [Full Text] [Related]

  • 22. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy.
    Gross A, Albrecht T.
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):402-410. PubMed ID: 31705244
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH.
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.
    Idilman I, Peynircioğlu B, Cil BE, Doğanay Erdoğan B, Yalçın S, Bayraktar Y, Kav T, Altundağ K, Balkancı F.
    Turk J Gastroenterol; 2013 Mar; 24(2):141-7. PubMed ID: 23934461
    [Abstract] [Full Text] [Related]

  • 27. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
    Kawai N, Sato M, Minamiguchi H, Ikoma A, Sanda H, Nakata K, Sato H, Sakaguchi H, Nakai M, Sonomura T.
    J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
    [Abstract] [Full Text] [Related]

  • 28. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ, Zheng JS, Cui SC, Cui XW, Hu CX, Fang D, Ye LC.
    World J Gastroenterol; 2015 Mar 14; 21(10):3035-40. PubMed ID: 25780303
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
    Kim DY, Ryu HJ, Choi JY, Park JY, Lee DY, Kim BK, Kim SU, Ahn SH, Chon CY, Han KH.
    Aliment Pharmacol Ther; 2012 Jun 14; 35(11):1343-50. PubMed ID: 22486716
    [Abstract] [Full Text] [Related]

  • 31. Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients.
    Gruber-Rouh T, Kamal A, Eichler K, Naguib NN, Beeres M, Langenbach M, Vogl TJ.
    Oncol Res Treat; 2018 Jun 14; 41(7-8):438-442. PubMed ID: 30007958
    [Abstract] [Full Text] [Related]

  • 32. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
    Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M.
    J Hepatol; 2012 Apr 14; 56(4):886-92. PubMed ID: 22173160
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin.
    Yoo SH, Kwon JH, Nam SW, Lee JY, Kim YW, Shim DJ, Lee SW, Jang JW.
    Cancer Control; 2020 Apr 14; 27(2):1073274820935843. PubMed ID: 32583687
    [Abstract] [Full Text] [Related]

  • 38. Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents.
    Chen S, Yu W, Zhang K, Liu W, Chen Q.
    Medicine (Baltimore); 2018 May 14; 97(21):e10832. PubMed ID: 29794774
    [Abstract] [Full Text] [Related]

  • 39. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.
    Xu LF, Sun HL, Chen YT, Ni JY, Chen D, Luo JH, Zhou JX, Hu RM, Tan QY.
    J Gastroenterol Hepatol; 2013 Mar 14; 28(3):456-63. PubMed ID: 23216261
    [Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of 70-150 μm and 100-300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
    Deipolyi AR, Oklu R, Al-Ansari S, Zhu AX, Goyal L, Ganguli S.
    J Vasc Interv Radiol; 2015 Apr 14; 26(4):516-22. PubMed ID: 25704226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.